Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMelrose Regulatory News (MRO)

Share Price Information for Melrose (MRO)

Share Price is delayed by 15 minutes
Get Live Data
453.70    -5.90 (-1.28%)
Bid:
454.70
Ask:
454.90
Spread: 0.20 (0.044%)
Market Cap: £5.65b
MRO Live PriceLast checked at - London Stock Exchange

Intraday Melrose Share Chart

Financing Update

4 Aug 2020 07:00

RNS Number : 0505V
Melrose Industries PLC
04 August 2020
 

MELROSE INDUSTRIES PLC

 

4 August 2020

 

 

FINANCING UPDATE

 

Melrose Industries PLC ("Melrose" or the "Group") today issues an update on financing.

 

Following the trading updates on 30 March 2020 and 22 July 2020, Melrose has now agreed amended arrangements with its banking syndicate including improved financial covenants to 31 December 2022. Beyond that date the Group reverts to the original covenants for the balance of the facilities' term. These amendments cover all the Group's primary borrowing arrangements that contain financial covenants.

 

The Group's committed c.£3.2 billion revolving credit facility is repayable in January 2023 and the Group's committed term loan of c.£0.9 billion can be extended to April 2024 at Melrose's option. In addition to these committed banking lines the Group has two bonds: a £450 million bond maturing in September 2022 and a £300 million bond maturing in May 2032, neither of which contain financial covenants.

 

Melrose is grateful for the continued support of its lending banks which means that it has the flexibility it needs to continue to focus on cash generation and adapting the Group to current market conditions. The new financial covenants have been designed to give Melrose considerable headroom and flexibility.

 

There is a modest cash cost to secure this amendment but there is no change to previously agreed interest rate calculations. Melrose has passed its covenant tests for 30 June 2020 and would not in fact have needed the net debt: EBITDA waiver granted previously.

 

The improved financial covenants are shown in the table below:

 

Financial

Covenant

31 December 2020

30 June 2021

31 December 2021

30 June 2022

31 December 2022

Net debt :EBITDA

Waiver*

Waiver

5.25x**

4.75x**

4.0x**

EBITDA :Net finance charges

2.5x

3.0x

3.0x

3.25x

4.0x

*Announced on 30 March 2020

**Subject to downward adjustments upon certain material disposals

 

Following 31 December 2022, the financial covenants revert to 3.5x (for net debt: EDITDA) and remain at 4x (for EBITDA: net finance charges).

 

 

 

Simon Peckham, CEO of Melrose Industries PLC, said:

"We have now put in place new amended arrangements with our banks that last until the end of 2022. We thank our banks again for their continued support which gives us the headroom and flexibility to continue to focus on cash generation and adapt the Group as needed. Melrose also retains over £1 billion of cash liquidity. We are confident that we can position the Group to produce good returns for Shareholders."

- ends

 

Enquiries:

 

 

Montfort Communications:

Nick Miles

+44 (0) 20 3514 0897

+44 (0) 7973 130 669

miles@montfort.london

Charlotte McMullen

+44 (0) 20 3514 0897

+44 (0) 7921 881 800

mcmullen@montfort.london

Melrose Investor Relations:

+44 (0) 7974 974690

ir@melroseplc.net

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDEZLBBBVLXBBV
Date   Source Headline
1st Jun 202211:30 amRNSDirector/PDMR Shareholding
5th May 20224:09 pmRNSResult of AGM
5th May 20227:00 amRNSTrading Statement
7th Apr 20224:16 pmRNSDirector/PDMR Shareholding
31st Mar 20224:30 pmRNSNotice of AGM
25th Mar 20224:01 pmRNSStandard annual confirmation of post-offer
24th Mar 20224:33 pmRNSTR-1: Standard notification of major holdings
7th Mar 202211:20 amRNSDirector/PDMR Shareholding
3rd Mar 20222:10 pmRNSDirector/PDMR Shareholding
3rd Mar 20227:00 amRNSFinal Results
1st Mar 20222:45 pmRNSTR-1: Standard notification of major holdings
31st Dec 20218:27 amRNSDirector/PDMR Shareholding
10th Dec 20214:00 pmRNSDirector/PDMR Shareholding
2nd Nov 20213:24 pmRNSTR-1: Standard notification of major holdings
2nd Nov 20217:30 amRNSDirector Declaration
1st Nov 20218:00 amEQSEdison Investment Research Limited: Melrose Industries (MRO): Initiation - A proven, high-value creation model
25th Oct 20213:05 pmRNSDirector/PDMR Shareholding
22nd Oct 20215:00 pmRNSDirector/PDMR Shareholding
21st Oct 20213:50 pmRNSTR-1:Standard form notification of major holdings
8th Oct 20213:00 pmRNSTR-1:Standard form notification of major holdings
5th Oct 20217:00 amRNSTrading Statement
1st Oct 20214:30 pmRNSTR-1: Notification of major holdings
20th Sep 20215:20 pmRNSTR-1 Notification of major interest in shares
2nd Sep 20217:00 amRNSHalf-year Report
31st Aug 20217:00 amRNSReturn of Capital and Total Voting Rights
18th Aug 20215:00 pmRNSReturn of Capital and Total Voting Rights
30th Jul 20212:05 pmGNWForm 8.3 - Nortonlifelock Inc
9th Jul 202110:54 amRNSResults of General Meeting
24th Jun 20213:44 pmRNSDirector/PDMR Shareholding
22nd Jun 20213:31 pmRNSPosting of Circular and Notice of General Meeting
22nd Jun 20217:00 amRNSAir Management Disposal and Return of Capital
28th May 20214:00 pmRNSDirector/PDMR Shareholding
19th May 20214:48 pmRNSCapital Markets Event
6th May 20211:45 pmRNSResults of GM and AGM
6th May 20217:00 amRNSTrading Statement AGM
20th Apr 20213:34 pmRNSPosting of Circular and Notice of General Meeting
19th Apr 20217:00 amRNSProposed Disposal of Nortek Air Management
9th Apr 20217:00 amRNSAppointment of Non-Executive Directors
31st Mar 20214:30 pmRNSAnnual Financial Report
26th Mar 20215:00 pmRNSStandard annual confirmation of POUs
4th Mar 20214:04 pmRNSDirector/PDMR Shareholding
4th Mar 20217:00 amRNSFinal Results
21st Jan 20214:45 pmRNSResult of Meeting
4th Jan 20217:00 amRNSAppointment of Executive Director
29th Dec 202012:30 pmRNSPosting of Circular and Notice of General Meeting
8th Dec 20204:05 pmRNSHolding(s) in Company
25th Nov 20207:00 amRNSTrading Statement
25th Sep 20209:51 amRNSDirector/PDMR Shareholding
3rd Sep 20207:00 amRNSHalf-year Report
4th Aug 20207:00 amRNSFinancing Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.